Biography:
Davide Garrisi holds a doctorate degree in Pharmaceutical Chemistry and Technology from the University of Padua (Italy) and an executive MBA from ALTIS/Catholic University of Milan/IlSole24 ore. He was appointed roles of increasing responsibilities in the CRO business, and he is currently Renal and Metabolic Therapeutic Area Lead in Cardiovascular and General Medicine at PPD, part of Thermo Fisher Scientific. He is also author and co-author of several posters and publications about the biotech industry and other topics in a variety of therapeutic areas.
Use of a large real-world dataset to define representative US populations for phase III obesity studies